Emerging research demonstrates that the aging immune system’s diminished capacity to regulate gut microbiota represents a critical mechanism underlying age-related disease development. As immunological control weakens, pathogenic microorganisms proliferate while beneficial bacterial populations decline, fundamentally altering microbial community structure.
This microbiome imbalance triggers a cascade of inflammatory responses known as ‘inflammaging,’ which contributes to cardiovascular disease, cognitive decline, and other age-related conditions. The loss of microbial diversity particularly impairs the production of short-chain fatty acids—compounds essential for controlling systemic inflammation.
These findings suggest that therapeutic interventions targeting immune function restoration may offer new strategies for healthy aging. By understanding the mechanisms connecting immunosenescence and microbiome disruption, researchers identify potential points for clinical intervention before age-related pathology becomes established.
Read the full article on GMJ Newsroom.
Was this article helpful?
